<?xml version="1.0" encoding="UTF-8"?>
<p id="par0270">The spike glycoprotein from SARS-CoV is a promising drug target. In this regard, a lectin called Griffithsin derived from red algae is known to be able to bind several viral glycoproteins, including SARS-CoV spike glycoprotein and HIV glycoprotein. Griffithsin was used in a preventive evaluated test to HIV, as gel and enema. However, to reach a preventive treatment to SARS-CoV-2, the delivery systems of spike inhibitors needs to be reevaluated [
 <xref rid="bib0590" ref-type="bibr">118</xref>,
 <xref rid="bib0720" ref-type="bibr">144</xref>]. No record was found regarding the effects of Griffithsin on pregnant women.
</p>
